HOME >> BIOLOGY >> NEWS
Researchers develop fast track way to discover how cells are regulated

SALT LAKE CITY, Sept. 17, 2004 -- Researchers at Huntsman Cancer Institute (HCI) at the University of Utah and a collaborator at the University of California at Santa Cruz report they have developed a unique computational approach to investigate a regulatory network for gene expression that is implicated in cell growth and development. The study was published today in the journal Science.

"When studying the genome of any organism, be it yeast, worm, fly or human, scientists are faced with a problem -- the incredible number of genes," explains Susan Mango, Ph.D., an HCI investigator and leader of the research team. Mango's research centered on a common garden-variety nematode worm, C. elegans, which shares many genes in common with humans. She explains that although worms appear simple, the worm genome is comprised of 20,000 genes. The human genome has over 30,000 genes. "When you look at the numbers, it becomes very clear that the old way -- studying one gene at a time -- is too slow. It becomes a problem of scale, with high throughput the only answer."

Mango's team used a unique process that combines microarray technology with computational approaches to predict, based on probabilities, where in the genome a particular regulatory sequence might be found. With co-authors Wanyuan Ao, Ph.D.; Jeb Gaudet, Ph.D.; James Kent, Ph.D.; and Srikanth Mattumu, Mango searched C. elegans's genome to find certain "punctuation marks" in the code that might be regulatory sequences responsible for the growth and development of the worm's foregut, or pharynx. They were able to identify a total of seven candidate gene sequences; after testing, they discovered that of the seven, five proved to be bona fide regulatory sequences.

"Up to now, identifying transcription factor target genes has been a challenge to biologists. Using our unique algorithm, the Improbizer algorithm developed by James Kent, one of our collaborators, we were able to pick out regulatory s
'"/>


17-Sep-2004


Page: 1 2

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers identify distinctive signature for metastatic prostate cancer
8. Researchers report new gene test for isolated cleft lip and palate
9. Researchers discover why mutant gene causes colon cancer
10. Researchers identify the genomes controlling elements
11. Researchers improve detection of diverse anthrax strains

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... August 25, 2020 , ... ... in partnership with Essex Bio-Technology, a bio-pharmaceutical company specializing in Ophthalmology and ... study of SkQ1 ophthalmic solution in patients with moderate to severe Dry ...
(Date:8/21/2020)... ... August 18, 2020 , ... ... today announced that the U.S. Food and Drug Administration (FDA) has approved the ... SBI-101, for the treatment of severe COVID-19. Approval of this IND allows Sentien ...
(Date:8/12/2020)... ... August 11, 2020 , ... Both ... NJ, have entered into license agreements with Housey Pharma’s HMI subsidiary to gain ... and J&J have annual Research and Development spending in excess of US $10 ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to deliver ... “It’s the only technology of its kind on the market and we were pleased ... the protective capacity of traditional cultured ingredients, creating a natural way to extend the ...
(Date:7/10/2020)... ... July 08, 2020 , ... ... announces a significant expansion of laboratory operations through its COVID-19 testing service, ... testing programs. , Bode-CARES provides a turnkey solution that includes ...
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien Biotechnologies, Inc., a ... of Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. ... lead product, SBI-101. Dr. Nissenson serves as an Emeritus Professor of Medicine ...
(Date:7/1/2020)... ... 29, 2020 , ... MedShift , a leading medical ... many obstacles created as a result of COVID-19. As a provider at the ... practices and medical manufacturers by expanding access to device offerings, technology services, and ...
Breaking Biology Technology:
Cached News: